Elena Yu. Antropova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Yu. Antropova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Madina I. Mazitova
Kazan State Medical Academy – branch of Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation
4 shared publications - Bulat M. Sharafutdinov
Russian Medical Academy of Postgraduate Education; Kazan State Medical Academy; Republican Clinical Oncological Dispansery named after Professor M.Z. Sigal
3 shared publications - Sergey Aleksandrovich Ryzhkin
Russian Medical Academy of Continuous Professional Education
3 shared publications - I. V. Klyucharov
Kazan (Volga Region) Federal University
2 shared publications - Airat F. Khalirakhmanov
Medical and Sanitary Unit, Kazan (Volga Region) Federal University; Kazan (Volga Region) Federal University
1 shared publication - Dilyara R. Khusnutdinova
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, 420008 Kazan, Russia
1 shared publication
Latest Publications
- Open Access
- 22 November 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (4) , 655-662
Features of Angioarchitectonics of Uterus in Uterine Leiomyoma: a Series of Clinical Observations
INTRODUCTION: One of most important problems in the gynecological practice is the choice of the treatment method of uterine leiomyoma. Uterine artery embolization has been practiced in the Republic of Tatarstan (Kazan), since 2004. Individual peculiarities of blood supply to the uterus and ovaries become the cause of failure of the endovascular treatment of patients with uterine leiomyoma in 20%–25% of cases forcing the doctors to resort to traditional surgical methods. The article presents a series of clinical cases demonstrating variants of angioarchitectonics of uterus and the results of the analysis of uterine artery embolization (UAE, n = 1743) performed at the department of X-ray surgical methods of diagnostics and treatment in the Primary healthcare unit of Kazan (Privolzhsk) Federal University. CONCLUSION: Endovascular occlusion of uterine arteries in patients with uterine myoma is a fairly effective method of treatment of this disease, and an adequate assessment of the peculiarities of the angioarchitectonics of uterus in uterine myoma permits to considerably increase the effectiveness of treatment and reduce the frequency of complications. The presented series of clinical observations from the clinical archive of the authors’ team demonstrates the variants of angioarchitectonics of uterus.
- 22 November 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (4) , 655-662
Open AccessFeatures of Angioarchitectonics of Uterus in Uterine Leiomyoma: a Series of Clinical Observations
INTRODUCTION: One of most important problems in the gynecological practice is the choice of the treatment method of uterine leiomyoma. Uterine artery embolization has been practiced in the Republic of Tatarstan (Kazan), since 2004. Individual peculiarities of blood supply to the uterus and ovaries become the cause of failure of the endovascular treatment of patients with uterine leiomyoma in 20%–25% of cases forcing the doctors to resort to traditional surgical methods. The article presents a series of clinical cases demonstrating variants of angioarchitectonics of uterus and the results of the analysis of uterine artery embolization (UAE, n = 1743) performed at the department of X-ray surgical methods of diagnostics and treatment in the Primary healthcare unit of Kazan (Privolzhsk) Federal University. CONCLUSION: Endovascular occlusion of uterine arteries in patients with uterine myoma is a fairly effective method of treatment of this disease, and an adequate assessment of the peculiarities of the angioarchitectonics of uterus in uterine myoma permits to considerably increase the effectiveness of treatment and reduce the frequency of complications. The presented series of clinical observations from the clinical archive of the authors’ team demonstrates the variants of angioarchitectonics of uterus.
- 15 December 2021
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 29 (4) , 545-556
Success and unsolved issues of embolization of the uterine arteries in uterine fibroid
Introduction: According to the clinical recommendations of the Healthcare Ministry of Russia (2021), uterine artery embolization (UAE) in uterine fibroid is an alternative to surgical treatment in case of high surgical risk and absence of contraindications in women who do not desire pregnancy. The advantages of UAE are associated with lesser blood loss, shorter hospital stay, and recovery of the working capacity. Here, we present an analysis of the literature and our 14-year clinical experience in performing UAE in uterine fibroid. Screening and primary diagnosis of uterine fibroid and indications and contraindications of UAE in the current publications were analyzed. Different methods of EUA implementation were described, and the advantages of the transradial access (TRA) are demonstrated on the basis of the actual clinical experience. Conclusion: The results obtained in the use of TRA revealed the reduction of radioscopy time and surgery time in general, which are beneficial in terms of the reduction of radiation exposure. Besides, an argument for the given access is a considerably lower frequency of serious complications at the access site. The main obstacles to the introduction and wide use of TRA are based on the lack of specialist experience, absence of specialized training programs, and use of unsuitable and traumatizing instruments. One of the unsolved questions is the absence of an anesthesia protocol, which must be developed with the participation of both gynecologists and specialists on X-ray endovascular diagnostics and treatment.
- 15 December 2021
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 29 (4) , 545-556
Success and unsolved issues of embolization of the uterine arteries in uterine fibroid
Introduction: According to the clinical recommendations of the Healthcare Ministry of Russia (2021), uterine artery embolization (UAE) in uterine fibroid is an alternative to surgical treatment in case of high surgical risk and absence of contraindications in women who do not desire pregnancy. The advantages of UAE are associated with lesser blood loss, shorter hospital stay, and recovery of the working capacity. Here, we present an analysis of the literature and our 14-year clinical experience in performing UAE in uterine fibroid. Screening and primary diagnosis of uterine fibroid and indications and contraindications of UAE in the current publications were analyzed. Different methods of EUA implementation were described, and the advantages of the transradial access (TRA) are demonstrated on the basis of the actual clinical experience. Conclusion: The results obtained in the use of TRA revealed the reduction of radioscopy time and surgery time in general, which are beneficial in terms of the reduction of radiation exposure. Besides, an argument for the given access is a considerably lower frequency of serious complications at the access site. The main obstacles to the introduction and wide use of TRA are based on the lack of specialist experience, absence of specialized training programs, and use of unsuitable and traumatizing instruments. One of the unsolved questions is the absence of an anesthesia protocol, which must be developed with the participation of both gynecologists and specialists on X-ray endovascular diagnostics and treatment.
- Open Access
- 23 July 2021
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 102 (3) , 172-177
Endovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids
Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.
- 23 July 2021
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 102 (3) , 172-177
Open AccessEndovascular Embolization of the Uterine Arteries in Giant Uterine Fibroids
Choosing a treatment option for uterine fibroids is today one of the most relevant problems in gynecological practice. Thanks to the success of modern medicine and the increased level of the population’s culture, female patients seek medical help without waiting for the tumor to acquire significant sizes. However, in practice, there are cases when fibroids reach gigantic sizes. Hysterectomy is a traditional approach to treating uterine fibroids of these sizes according to the current clinical guidelines. The introduction of new high-tech treatments, such as uterine artery embolization, has led to a revision of radical surgery, by giving preference to alternative approaches especially in cases where the patient desires to preserve the reproductive organ. The paper describes a clinical case that confirms an individual approach to choosing a treatment option towards organ-sparing surgery for giant uterine fibroids. The use of endovascular embolization of the uterine arteries as a treatment for giant uterine fibroids is shown to be justified as an organ-sparing surgery if the patient desires to preserve reproductive function.
- 21 March 2020
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 83 (2) , 23-26
Мифепристон в терапии миомы матки у женщин репродуктивного возраста
Изучена эффективность мифепристона в адъювантной терапии миомы матки у женщин репродуктивного возраста. Всем больным было проведено общеклиническое исследование, трансвагинальное ультразвуковое сканирование с допплерометрией маточных и опухолевых сосудов, определение уровня гормонов в крови до применения мифепристона, через 3 и 6 мес после начала применения. Полученные данные о содержании в сыворотке крови фолитропина, лютропина, эстрадиола и прогестерона у больных, получающих мифепристон, подтверждают роль прогестерона в развитии миомы матки. Показано, что размеры миомы матки и доминантного узла по данным ультразвукового исследования уменьшились в 2,3 раза; интенсивность кровообращения через 6 мес приема препарата уменьшилась на 15,4 % (p < 0,01), что отражает положительный эффект мифепристона, а использование допплерометрических критериев на ранних этапах применения препарата обеспечивает неинвазивную оценку эффективности проводимого лечения.
- 21 March 2020
- Published by Folium Publishing Company in Экспериментальная и клиническая фармакология
- Vol. 83 (2) , 23-26
Мифепристон в терапии миомы матки у женщин репродуктивного возраста
Изучена эффективность мифепристона в адъювантной терапии миомы матки у женщин репродуктивного возраста. Всем больным было проведено общеклиническое исследование, трансвагинальное ультразвуковое сканирование с допплерометрией маточных и опухолевых сосудов, определение уровня гормонов в крови до применения мифепристона, через 3 и 6 мес после начала применения. Полученные данные о содержании в сыворотке крови фолитропина, лютропина, эстрадиола и прогестерона у больных, получающих мифепристон, подтверждают роль прогестерона в развитии миомы матки. Показано, что размеры миомы матки и доминантного узла по данным ультразвукового исследования уменьшились в 2,3 раза; интенсивность кровообращения через 6 мес приема препарата уменьшилась на 15,4 % (p < 0,01), что отражает положительный эффект мифепристона, а использование допплерометрических критериев на ранних этапах применения препарата обеспечивает неинвазивную оценку эффективности проводимого лечения.
- 1 January 2018
- Published by LLC Praktika in Practical medicine
- Vol. 16 (7(part 2)) , 45-50
Influence of embolization of uterine arteries on menstrual and reproductive functions (remote results and brief literature review)
- 1 January 2018
- Published by LLC Praktika in Practical medicine
- Vol. 16 (7(part 2)) , 45-50
Influence of embolization of uterine arteries on menstrual and reproductive functions (remote results and brief literature review)